VTRS
Viatris Inc.
VTRS lost money over the past year, so it has no meaningful PE right now. Analysts expect earnings to recover and profitability to improve.
VTRS Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Stable | |
| Strong | |
| Weak |
VTRS's cash flow is currently strong, and its revenue and profitability are stable, but its balance sheet is weak.
VTRS PE Valuation
VTRS has no meaningful PE right now: it lost money over the past year.
VTRS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Growth | |
| Growth | |
| Strongly improving | |
| Limited | |
| Moderate |
Analysts expect earnings and revenue growth for VTRS, with profitability improving.
VTRS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.65 | — |
| Q3 2026 | -$0.57 | +$2.52 |
| Q2 2026 | -$0.40 | +$2.50 |
| Q1 2026 | -$0.30 | +$2.87 |
| Q4 2025 | -$3.00 | -$2.47 |
| Q3 2025 | -$3.09 | -$2.36 |
| Q2 2025 | -$2.90 | -$2.36 |
| Q1 2025 | -$3.17 | -$3.12 |
| Q4 2024 | -$0.53 | -1160% |
VTRS is still losing money, but far less than before: $0.57 per share over the past year, against $3.17 at its worst in early 2025.
VTRS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $3.7B | -0.3% |
| Q2 2026 | $3.8B | +4.9% |
| Q1 2026 | $3.5B | +8.1% |
| Q4 2025 | $3.7B | +5% |
| Q3 2025 | $3.8B | +0.2% |
| Q2 2025 | $3.6B | -5.6% |
| Q1 2025 | $3.3B | -11% |
| Q4 2024 | $3.5B | -8.1% |
VTRS's revenue is growing: $3.7B last quarter, about level with the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 7% | +2.2 points |
| Q2 2026 | 0.2% | -6.3 points |
| Q1 2026 | -2.3% | +86 points |
| Q4 2025 | -5.2% | -0.1 points |
| Q3 2025 | 4.8% | -1.3 points |
| Q2 2025 | 6.5% | +13 points |
| Q1 2025 | -89% | -94 points |
| Q4 2024 | -5.1% | +6.7 points |
VTRS's operating margin was 7% last quarter, up 2.2 points from the same quarter a year ago.
VTRS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $813.7M | +24% |
| Q2 2026 | $329M | +97% |
| Q1 2026 | $348.4M | -29% |
| Q4 2025 | $619.3M | +81% |
| Q3 2025 | $658.1M | -12% |
| Q2 2025 | $166.8M | -48% |
| Q1 2025 | $492.9M | -13% |
| Q4 2024 | $342.3M | +9% |
VTRS generated $2.1B in free cash flow over the past year, up 27% from the year before.
VTRS Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 4.1x | High |
| Q2 2026 | 4.6x | High |
| Q1 2026 | 4.3x | High |
| Q4 2025 | 96.8x | High |
| Q3 2025 | 105.5x | High |
| Q2 2025 | 89.2x | High |
| Q4 2024 | 4.6x | High |
| Q3 2024 | 5.5x | High |
VTRS's net debt is about 4.1 years of its operating earnings (EBITDA), down from more than 20 years a year ago.
VTRS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 73.1 | Overbought |
| Stochastic | 92.0 | Overbought |
VTRS's weekly RSI is 73 (overbought) and its Stochastic is 92 (overbought).
VTRS PE vs Healthcare Sector
| Metric | VTRS | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 26x | — |
VTRS has no meaningful PE right now: it lost money over the past year.
VTRS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $18.7 | 11% above |
| 20 week MA | $17.5 | 18% above |
| 50 week MA | $15.6 | 33% above |
| 100 week MA | $12.7 | 63% above |
| 200 week MA | $11.8 | 75% above |
VTRS is in an uptrend: it's above all five of its weekly moving averages, and 75% above its 200-week average.
VTRS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $19.7 | $17.8 | -9.9% |
| 2021 | $17.8 | $13.6 | -23% |
| 2022 | $13.6 | $11.0 | -19% |
| 2023 | $11.0 | $10.8 | -1.6% |
| 2024 | $10.8 | $12.5 | +15% |
| 2025 | $12.5 | $12.3 | -1.3% |
| 2026 YTD | $12.3 | $20.7 | +68% |
VTRS is up 68% so far in 2026, after finishing lower in five of the previous six years.